Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

4.430

-0.030 (-0.67%)

At close: Feb 27, 2026, 4:00 PM EST

4.280

-0.150 (-3.39%)

After-hours: Feb 27, 2026, 7:47 PM EST

Anavex Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	411	764	482	537	804	1,359
Market Cap Growth	-44.53%	58.72%	-10.27%	-33.27%	-40.83%	396.34%
Enterprise Value	279	663	343	382	651	1,202
Last Close Price	4.43	8.90	5.68	6.55	10.32	17.95
PB Ratio	3.24	8.06	4.01	3.78	5.65	9.01
P/TBV Ratio	3.24	8.06	4.01	3.78	5.65	9.01
Net Debt / Equity Ratio	-1.04	-1.08	-1.10	-1.06	-1.05	-1.01
Quick Ratio	20.81	11.56	8.80	12.27	14.92	14.93
Current Ratio	20.87	11.61	8.86	12.32	14.95	14.97
Return on Equity (ROE)	-33.63%	-43.11%	-32.81%	-33.41%	-32.71%	-42.58%
Return on Assets (ROA)	-21.56%	-26.51%	-21.81%	-21.59%	-18.95%	-23.87%
Return on Capital Employed (ROCE)	-35.00%	-53.50%	-42.10%	-37.40%	-33.40%	-24.80%
Earnings Yield	-9.73%	-6.07%	-8.93%	-8.85%	-5.96%	-2.79%
Buyback Yield / Dilution	-2.61%	-2.18%	-4.61%	-3.74%	-10.18%	-19.95%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q